Ratings Van Lanschot Kempen N.V

Equities

VLK

NL0000302636

Real-time Euronext Amsterdam Other stock markets 05:07:23 2024-04-29 am EDT			5-day change	1st Jan Change
33.55 ^EUR	+1.51%		+2.60%	+19.18%

Apr. 18	Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds	MT
Mar. 07	Van Lanschot Kempen Plans Early Redemption of EUR100 Million Notes	MT

Strengths

The company returns high margins, thereby supporting business profitability.
The company is one of the best yield companies with high dividend expectations.
Analysts covering this company mostly recommend stock overweighting or purchase.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company's earnings growth outlook lacks momentum and is a weakness.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Investment Management & Fund Operators

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
VAN LANSCHOT KEMPEN N.V	+19.18%	1.49B		B-
SEI INVESTMENTS COMPANY	+4.75%	8.74B		B+
360 ONE WAM LIMITED	+13.83%	3.48B		C-
ST. JAMES'S PLACE PLC	-35.69%	2.96B		B
ASSETMARK FINANCIAL HOLDINGS, INC.	+13.29%	2.52B		B-
STEPSTONE GROUP LP	+14.51%	2.39B		C
HIGHEST PERFORMANCES HOLDINGS INC.	+42.63%	2.17B	-	-
UTI ASSET MANAGEMENT COMPANY LIMITED	+11.54%	1.49B		B
PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED	+12.30%	1.42B		B+
INSIGNIA FINANCIAL LTD.	+5.98%	1.02B		C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes